Les Funtleyder's most recent trade in Applied Therapeutics Inc was a trade of 150,000 Common Stock done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | Funtleyder Les | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 150,000 | 1,340,459 (7%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 2,375,000 | 152,959 (0%) | 12% | - | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2025 | 1,187,500 | 2,527,959 (13%) | 6% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | 19 Dec 2025 | 152,959 | 0 (0%) | 0% | - | Common Stock | ||
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 40,502 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 20,460 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 16,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 16,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Dec 2025 | 10,230 | 0 | - | - | Stock Option (Right to Buy) | |
| Reviva Pharma Holdings Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2025 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 150,000 | 1,190,459 (6%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 150,000 | 787,121 (4%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 150,000 | 937,121 (5%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2025 | 350,000 | 740,459 (3%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 04 Mar 2025 | 14,502 | 390,459 (2%) | 0% | 0.4 | 6,381 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 06 Feb 2025 | 22,950 | 404,961 (2%) | 0% | 0.6 | 14,000 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Funtleyder Les | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 427,911 (2%) | 0% | 0 | Common Stock | |
| Reviva Pharma Holdings Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.83 per share. | 22 Aug 2024 | 13,530 | 277,911 (1%) | 0% | 5.8 | 78,880 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 16,980 | 291,441 (1%) | 0% | 4.3 | 73,354 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 28,727 | 308,421 (1%) | 0% | 5.4 | 154,839 | Common Stock |
| Applied Therapeutics Inc | Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 300,000 | 337,148 (1%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 37,148 (0%) | 0% | 0 | Common Stock | |
| Reviva Pharma Holdings Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 3,900 | 3,900 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Reviva Pharma Holdings Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| Applied Therapeutics Inc | Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) |